Global Precision Medicine Software 2019-2025
|発行||Orion Market Research Pvt Ltd||商品コード||888694|
|精密医療（プレシジョンメディシン）ソフトウェアの世界市場 Global Precision Medicine Software 2019-2025|
|出版日: 2019年06月28日||ページ情報: 英文||
Global Precision Medicine Software Market Size, Share & Trends Analysis Report by Application (Oncology, Pharmacogenomics, and Rare diseases) and by End-User (Pharmaceutical and Biotechnology Companies, Hospital and Clinics, Research Centers and Government Institutes) and Forecast, 2019-2025
Precision medicine software is an essential data driven tools used by the healthcare providers and research institutes for the study of oncology, pharmacogenomics, and evaluation of the rare disease. Global precision medicine software market is growing due to various factors such as rising government initiatives for using precision medicine and entrance of new market players in the precision medicine software market. Moreover, the rising trends towards precision medicines in oncology and pharmacogenomics application would propel the market growth in the near future. However, concern related to the secure storage of a large amount of data may hamper market growth. The introduction of AI in precision medicine and rising cloud-based solutions further provides growth opportunities for the global precision medicine software market.
Geographically, the global precision medicine software market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America is projected to have a significant market share in the global precision medicine software market during the forecast period. The factors that are contributing to the growth of the market in the region includes well-developed healthcare infrastructure, rising number of cancer patients, and increasing R&D investment by the pharmaceutical and biotechnology companies for genomic research. Moreover, Asia-Pacific is estimated to exhibit considerable market growth in the global precision medicine software market during the forecast period. The growth is mainly due to the increasing collaborations between software and pharmaceutical companies to enhance the R&D activities. Moreover, the rising awareness for the use of precision medicine in cancer and other disease treatment is anticipated to propel the growth of the market in the region.
The global precision medicine software market is influenced by product development and technological advancements conducted by the market players. The key players of the global precision medicine software market include 2bPrecise, LLC, Gene42 Inc., Intel Corp., IBM Corp., Koninklijke Philips N.V., LifeOmic Health, LLC, PierianDx, Inc., Syapse, Inc., Tempus Labs, Translational Software Inc., NantHealth, Inc., and Genospace, LLC. These players are playing a significant role in the growth of the precision medicine software market by providing various innovative software solutions and adopting several strategies such as a merger and acquisition, partnerships and collaboration, technological development, and others. For instance, in January 2017, Genospace, LLC and Sarah Cannon announced the merger for the development of cancer care solution through precision medicine platform.
The market study of the global precision medicine software market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
The report is intended for precision medicine software providers, research institutes, biotechnology companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.